Regenstrief research scientists Jiang Bian, PhD and Jingchuan Serena Guo, MD, PhD, weigh in on emerging evidence in a new The Washington Post feature exploring potential benefits and unanswered questions around these widely used medications.
-
Research
- Experts
In The News
View AllAP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View AllPrimary Care and Survival: Implications for Research and Policy
Published in the Journal of General Internal Medicine. Here is a link...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Collaboration
Generating Evidence Across the Full Arc of Disease
Regenstrief Institute x Merck The Question Clinical trials establish whether...
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief, Triomics and Indiana University Health, supported by an independent...
- Experts



